Edition:
United States

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

39.37USD
22 Jun 2018
Change (% chg)

$-0.41 (-1.03%)
Prev Close
$39.78
Open
$39.80
Day's High
$39.97
Day's Low
$39.07
Volume
1,158,551
Avg. Vol
376,246
52-wk High
$45.02
52-wk Low
$15.28

Chart for

About

Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly... (more)

Overall

Beta: --
Market Cap(Mil.): $1,858.44
Shares Outstanding(Mil.): 47.20
Dividend: --
Yield (%): --

Financials

  EDIT.OQ Industry Sector
P/E (TTM): -- 248.83 34.14
EPS (TTM): -2.81 -- --
ROI: -33.48 -5.25 13.10
ROE: -52.94 -6.83 15.09

BRIEF-Editas Medicine Reports Data Demonstrating Subretinal Injection Of Edit-101 Well-Tolerated In Non-Human Primates

* EDITAS MEDICINE REPORTS DATA DEMONSTRATING SUBRETINAL INJECTION OF EDIT-101 WELL-TOLERATED IN NON-HUMAN PRIMATES

May 18 2018

BRIEF-Editas Medicine Reports Q1 Loss Per Share Of $0.67

* EDITAS MEDICINE ANNOUNCES FIRST QUARTER 2018 RESULTS AND UPDATE

May 03 2018

BRIEF-Editas Medicine Names James Mullen As Chairman Of Board

* EDITAS MEDICINE NAMES JAMES C. MULLEN AS CHAIRMAN OF THE BOARD OF DIRECTORS

Mar 28 2018

BRIEF-Editas Medicine Inc Files For Mixed Shelf Of Up To $150 Million – SEC Filing‍​

* EDITAS MEDICINE INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text (http://bit.ly/2GlXQp9) Further company coverage: (Reuters.Brief@thomsonreuters.com)

Mar 12 2018

BRIEF-Editas Medicine Q4 Loss Per Share $0.84

* EDITAS MEDICINE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS AND UPDATE

Mar 06 2018

BRIEF-Adverum Biotechnologies Extends Collaboration Agreement With Editas Medicine

* ANNOUNCES EXTENSION OF ITS COLLABORATION AGREEMENT WITH EDITAS MEDICINE INC

Jan 25 2018

Earnings vs. Estimates